Fig. 4. Suppression of tumor growth by resveratrol in xenograft models. Res (200 mg/kg, i.p., 3 times/week) was treated into RKO cells- and WiDr cells-derived xenograft models. (A) Tumor growth delay. (B) Change in body weight in xenograft models. (C) Survival rate of Res in RKO cells-derived xenograft model. All data represent the mean ± SD (n=5). *p<0.05 (Two-way ANOVA with Sidak’s post hoc test). (D) Protein expression levels of tumor tissues derived from xenograft models. Data represent the mean ± SD (n=6). *p<0.05, **p<0.0001 (Two-way ANOVA with Sidak’s post hoc test).
© Biomolecules & Therapeutics
